Sep 12, 2023 / 12:50PM GMT
Jeff Hung - Morgan Stanley, Research Division - Equity Analyst
Welcome to the Morgan Stanley Global Healthcare Conference. I'm Jeff Hung, one of the biotech analyst. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
For this session, we have Ultragenyx with CEO, Emil Kakkis. Welcome, Emil.
Emil D. Kakkis - Ultragenyx Pharmaceutical Inc. - Founder, President, CEO & Director
Thanks for having me, Jeff.
Questions and Answers:
Jeff Hung - Morgan Stanley, Research Division - Equity AnalystSo for those who may not be familiar with Ultragenyx, can you provide a brief introduction?
Emil D. Kakkis - Ultragenyx Pharmaceutical Inc. - Founder, President, CEO & Director
Sure, Jeff. Ultragenyx now has been -